The part of AI spending that is growing fastest right now is not the part getting the most attention Enterprises are ...

Adam Harris is drawing a line between the AI that wins demos and the AI that runs a hotel at 2 a.m. without triggering a ...

That distinction between potential and real application is the one Wymore built his entire session around. The most ...

A new interest will often expose us to people with different backgrounds, demographics, and life experiences from the bulk of ...

Research from Forrester has long emphasized the size and complexity of B2B buying groups, reinforcing what many of us see every day. Earlier this year, the research firm reported that “the typical ...

Mipletamig continues to perform, delivers 87% clinical benefit and 81% remission in frontline AML, with no CRS in frontline ...

Enterprises locked in GPU capacity during the AI scramble. Now utilization sits at 5% and the bill is due. Here's what the data says about where the market is heading.

Miovision today introduced the world's first GenAI-informed, end-to-end traffic signal optimization and retiming solution on Miovision One, giving cities and transportation agencies a faster, more ...

It’s important for founders to have a working knowledge of AI’s capabilities, but for some jobs, it pays to call in an expert.

Blue Yonder's ICON 2026 day two delivered a raft of product announcements - including cognitive solutions for category ...

What are marketing and comms leaders to do when faced with the double whammy of managing startup pivots while the marketing ...

Initiation of a Phase I/IIa first-in-human trial for GLIX1 in glioblastoma (GBM) was announced, with the first patient dosed at NYU Langone Health; two additional academic centers (Northwestern ...